Iovance Biotherapeutics (IOVA) Work In Process (2023 - 2025)
Iovance Biotherapeutics (IOVA) posted quarterly Work In Process of $12.1 million for Q1 2025, up 104.4% year-over-year from $5.9 million in Q1 2024, and up 37.91% quarter-over-quarter from $8.8 million in Q4 2024.
Iovance Biotherapeutics (IOVA) Work In Process (2023 - 2025) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Work In Process for 3 consecutive years, with $12.1 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Work In Process rose 104.4% year-over-year to $12.1 million; the TTM figure through Mar 2025 stood at $12.1 million (up 104.4% YoY), while the FY2024 annual figure was $8.8 million, up 52.46% from the prior year.
- Work In Process climbed to $12.1 million in Q1 2025 per IOVA's latest filing, from $8.8 million in the prior quarter.
- Across five years, Work In Process topped out at $12.1 million in Q1 2025 and bottomed at $4.3 million in Q3 2023.
- Historically, Work In Process has averaged $7.6 million across 3 years, with a median of $7.3 million in 2023.
- Annual changes were most pronounced in 2024 — Work In Process surged 52.46% — and 2025, when it jumped 104.4%.
- Iovance Biotherapeutics' Work In Process stood at $5.7 million in 2023, then soared by 52.46% to $8.8 million in 2024, then surged by 37.91% to $12.1 million in 2025.
- Business Quant data shows IOVA's Work In Process at $12.1 million in Q1 2025, $8.8 million in Q4 2024, and $5.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 12.09 Mn |
| Dec 31, 2024 | 8.77 Mn |
| Mar 31, 2024 | 5.91 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 4.30 Mn |
| Jun 30, 2023 | 8.59 Mn |